Frederick K. Goodwin, M.D.

Frederick K. Goodwin, M.D., is research professor of psychiatry at George Washington University. He is the director of the Psychopharmacology Research Center and the Center on Neuroscience, Medical Progress, and Society at the George Washington University Medical Center. He is a specialist in manic-depressive illness.

Frederick Goodwin received his M.D. from St. Louis University, and was a psychiatric resident at the University of North Carolina in Chapel Hill. Before moving to Georgetown, Dr. Goodwin was director of the National Institute of Mental Health (NIMH), from 1981 to 1988. Earlier, he was head of the Alcohol, Drug Abuse, and Mental Health Administration. He is known in particular for having been the first to report a controlled study on the antidepressant effects of lithium.

He is a member of the Institute of Medicine of the National Academy of Sciences and a fellow of the ACNP. He is a founder of the journal Psychiatry Research, and on the editorial boards of a number of other journals. He was president of the Psychiatric Research Society, elected in 1998.

Awards

• Hofheimer Prize from the American Psychiatric Association
• International Anna-Monika Prize for Research in Depression
• Edward A. Strecker Award
• Lieber Prize from NARSAD
• McAlpin Award
• Distinguished Service Award from NAMI,
• Research Award from the American Foundation for Suicide Prevention
• "Psychiatrist of the Year" from Psychiatric Times (first recipient)
• Fawcett Humanitarian Award of the NDMDA (first recipient)

Publications

With K. R. Jamison, he wrote Manic-Depressive Illness, the first psychiatric text to win the "Best Medical Book" award from the Association of American Publishers. In addition, Dr. Goodwin is the host of the The Infinite Mind, a weekly public radio program.

See also

• Violence Initiative